Skip to main content
Logo
Contact
Search

Main navigation

  • About
    • What is AMR?
    • Our People
    • Governance & Leadership
  • Research
    • Animal Antibiotics
    • Human Antibiotics
    • Global Surveillance of AMR
    • Digital Microbiology and Evolution
    • Bacteriophages
  • Opportunities
    • Training & Education
    • Careers
    • Grand Challenge and Synergy Grants
  • Engagement
    • Events
    • Outreach
    • Global action against AMR
    • Not in our lifetime
  • News
    • News
    • Publications
  • Oxford AMR Network
  • About
    • What is AMR?
    • Our People
    • Governance & Leadership
  • Research
    • Animal Antibiotics
    • Human Antibiotics
    • Global Surveillance of AMR
    • Digital Microbiology and Evolution
    • Bacteriophages
  • Opportunities
    • Training & Education
    • Careers
    • Grand Challenge and Synergy Grants
  • Engagement
    • Events
    • Outreach
    • Global action against AMR
    • Not in our lifetime
  • News
    • News
    • Publications
  • Oxford AMR Network

NEWS & PUBLICATIONS

Publications

Emergence of plasmid-mediated tigecycline resistance tet(X4) gene in Escherichia coli isolated from poultry, food and the environment in South Asia

Willames Martins
Published
2021
Global surveillance of AMR

Structural and mechanistic insights into the artemis endonuclease and strategies for its inhibition

Chris Schofield
Published
2021
Drug discovery

X-ray free-electron laser studies reveal correlated motion during isopenicillin N synthase catalysis

Chris Schofield
Published
2021
Drug discovery

What is the catalytic mechanism of enzymatic histone N-methyl arginine demethylation and can it be influenced by an external electric field?

Chris Schofield
Published
2021
Drug discovery

High-throughput crystallography reveals boron-containing inhibitors of a penicillin-binding protein with di- and tricovalent binding modes

Chris Schofield
Published
2021
Drug discovery

Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: An international microbiology and drug evaluation prospective substudy (BARNARDS)

Katy Thomson
Published
2021
Global surveillance of AMR
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Next page Next ›
Logo

Ineos Oxford Institute for antimicrobial research

University of Oxford

Sir William Dunn School of Pathology

South Parks Road

Oxford, OX1 3RE

United Kingdom

info@ineosoxford.ox.ac.uk

FOLLOW US

© 2024
Privacy Google